お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は皮膚科治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは皮膚科治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の皮膚科治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは皮膚科治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に皮膚科治療市場を分類しています。本研究に含まれる主な企業は：AGI Dermatics、Allergan、Amgen、Chester Valley、Dermik、Eisai、Ferndale、Genentech、Medicis、Onset Therapeutics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Anti-infectives
    Corticosteroids
    Anti Psoriasis
    Anti-acne
    Others

用途別の市場セグメント：
    Hospital
    Clinic

本レポートの詳細内容
世界の皮膚科治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、皮膚科治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の皮膚科治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の皮膚科治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、皮膚科治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

皮膚科治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：皮膚科治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：皮膚科治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章皮膚科治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：皮膚科治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：皮膚科治療の主要企業の概要を提供し、製品の説明と仕様、皮膚科治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Dermatological Therapeutics Market
The global Dermatological Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Dermatological Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Dermatological Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Dermatological Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dermatological Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Dermatological Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Dermatological Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including AGI Dermatics, Allergan, Amgen, Chester Valley, Dermik, Eisai, Ferndale, Genentech and Medicis, etc.

Market Segmentation
By Company
    AGI Dermatics
    Allergan
    Amgen
    Chester Valley
    Dermik
    Eisai
    Ferndale
    Genentech
    Medicis
    Onset Therapeutics

Segment by Type
    Anti-infectives
    Corticosteroids
    Anti Psoriasis
    Anti-acne
    Others

Segment by Application
    Hospital
    Clinic

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Dermatological Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dermatological Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Dermatological Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Anti-infectives
    Table 3. Key Players of Corticosteroids
    Table 4. Key Players of Anti Psoriasis
    Table 5. Key Players of Anti-acne
    Table 6. Key Players of Others
    Table 7. Global Dermatological Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Dermatological Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Dermatological Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Dermatological Therapeutics Market Share by Region (2019-2024)
    Table 11. Global Dermatological Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Dermatological Therapeutics Market Share by Region (2025-2030)
    Table 13. Dermatological Therapeutics Market Trends
    Table 14. Dermatological Therapeutics Market Drivers
    Table 15. Dermatological Therapeutics Market Challenges
    Table 16. Dermatological Therapeutics Market Restraints
    Table 17. Global Dermatological Therapeutics Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Dermatological Therapeutics Revenue Share by Players (2019-2024)
    Table 19. Global Top Dermatological Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Therapeutics as of 2023)
    Table 20. Global Dermatological Therapeutics Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Dermatological Therapeutics Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Dermatological Therapeutics, Headquarters and Area Served
    Table 23. Global Key Players of Dermatological Therapeutics, Product and Application
    Table 24. Global Key Players of Dermatological Therapeutics, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Dermatological Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Dermatological Therapeutics Revenue Market Share by Type (2019-2024)
    Table 28. Global Dermatological Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Dermatological Therapeutics Revenue Market Share by Type (2025-2030)
    Table 30. Global Dermatological Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Dermatological Therapeutics Revenue Share by Application (2019-2024)
    Table 32. Global Dermatological Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Dermatological Therapeutics Revenue Share by Application (2025-2030)
    Table 34. North America Dermatological Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Dermatological Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Dermatological Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Dermatological Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Dermatological Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Dermatological Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Dermatological Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Dermatological Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Dermatological Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Dermatological Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Dermatological Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Dermatological Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Dermatological Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Dermatological Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Dermatological Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Dermatological Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Dermatological Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Dermatological Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Dermatological Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Dermatological Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Dermatological Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Dermatological Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Dermatological Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Dermatological Therapeutics Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Dermatological Therapeutics Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Dermatological Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size by Country (2025-2030) & (US$ Million)
    Table 66. AGI Dermatics Company Details
    Table 67. AGI Dermatics Business Overview
    Table 68. AGI Dermatics Dermatological Therapeutics Product
    Table 69. AGI Dermatics Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 70. AGI Dermatics Recent Developments
    Table 71. Allergan Company Details
    Table 72. Allergan Business Overview
    Table 73. Allergan Dermatological Therapeutics Product
    Table 74. Allergan Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 75. Allergan Recent Developments
    Table 76. Amgen Company Details
    Table 77. Amgen Business Overview
    Table 78. Amgen Dermatological Therapeutics Product
    Table 79. Amgen Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 80. Amgen Recent Developments
    Table 81. Chester Valley Company Details
    Table 82. Chester Valley Business Overview
    Table 83. Chester Valley Dermatological Therapeutics Product
    Table 84. Chester Valley Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 85. Chester Valley Recent Developments
    Table 86. Dermik Company Details
    Table 87. Dermik Business Overview
    Table 88. Dermik Dermatological Therapeutics Product
    Table 89. Dermik Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 90. Dermik Recent Developments
    Table 91. Eisai Company Details
    Table 92. Eisai Business Overview
    Table 93. Eisai Dermatological Therapeutics Product
    Table 94. Eisai Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 95. Eisai Recent Developments
    Table 96. Ferndale Company Details
    Table 97. Ferndale Business Overview
    Table 98. Ferndale Dermatological Therapeutics Product
    Table 99. Ferndale Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 100. Ferndale Recent Developments
    Table 101. Genentech Company Details
    Table 102. Genentech Business Overview
    Table 103. Genentech Dermatological Therapeutics Product
    Table 104. Genentech Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 105. Genentech Recent Developments
    Table 106. Medicis Company Details
    Table 107. Medicis Business Overview
    Table 108. Medicis Dermatological Therapeutics Product
    Table 109. Medicis Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 110. Medicis Recent Developments
    Table 111. Onset Therapeutics Company Details
    Table 112. Onset Therapeutics Business Overview
    Table 113. Onset Therapeutics Dermatological Therapeutics Product
    Table 114. Onset Therapeutics Revenue in Dermatological Therapeutics Business (2019-2024) & (US$ Million)
    Table 115. Onset Therapeutics Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dermatological Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Dermatological Therapeutics Market Share by Type: 2023 VS 2030
    Figure 3. Anti-infectives Features
    Figure 4. Corticosteroids Features
    Figure 5. Anti Psoriasis Features
    Figure 6. Anti-acne Features
    Figure 7. Others Features
    Figure 8. Global Dermatological Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Dermatological Therapeutics Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Dermatological Therapeutics Report Years Considered
    Figure 13. Global Dermatological Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Dermatological Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Dermatological Therapeutics Market Share by Region: 2023 VS 2030
    Figure 16. Global Dermatological Therapeutics Market Share by Players in 2023
    Figure 17. Global Top Dermatological Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dermatological Therapeutics as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Dermatological Therapeutics Revenue in 2023
    Figure 19. North America Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Dermatological Therapeutics Market Share by Type (2019-2030)
    Figure 21. North America Dermatological Therapeutics Market Share by Application (2019-2030)
    Figure 22. North America Dermatological Therapeutics Market Share by Country (2019-2030)
    Figure 23. United States Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Dermatological Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Dermatological Therapeutics Market Share by Type (2019-2030)
    Figure 27. Europe Dermatological Therapeutics Market Share by Application (2019-2030)
    Figure 28. Europe Dermatological Therapeutics Market Share by Country (2019-2030)
    Figure 29. Germany Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Dermatological Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Dermatological Therapeutics Market Share by Type (2019-2030)
    Figure 37. China Dermatological Therapeutics Market Share by Application (2019-2030)
    Figure 38. Asia Dermatological Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Dermatological Therapeutics Market Share by Type (2019-2030)
    Figure 40. Asia Dermatological Therapeutics Market Share by Application (2019-2030)
    Figure 41. Asia Dermatological Therapeutics Market Share by Region (2019-2030)
    Figure 42. Japan Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Dermatological Therapeutics Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Dermatological Therapeutics Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Dermatological Therapeutics Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Dermatological Therapeutics Market Share by Country (2019-2030)
    Figure 52. Brazil Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Dermatological Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. AGI Dermatics Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 59. Allergan Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 60. Amgen Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 61. Chester Valley Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 62. Dermik Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 63. Eisai Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 64. Ferndale Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 65. Genentech Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 66. Medicis Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 67. Onset Therapeutics Revenue Growth Rate in Dermatological Therapeutics Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed